Global disease burden due to antibiotic resistance - State of the evidence

Journal of Global Health

Volumn 6, Issue 1, 2016, Pages

  Woolhouse, Mark ^a,b   Waugh, Catriona ^a   Perry, Meghan Rose ^a,c   Nair, Harish ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84999114768     PISSN: 20472978     EISSN: 20472986     Source Type: Journal    
DOI: 10.7189/jogh.06.010306     Document Type: Article

References (13)

1. Woolhouse M, Farrar J. An intergovernmental panel on antimicrobial resistance. Nature. 2014;509:555-7. Medline:24877180 doi:10.1038/509555a
2. Laxminarayan R, Matsoso P, Pant S, Brower C, Rottingen JA, Klugman K, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387:168-75. Medline:26603918 doi:10.1016/S0140-6736(15)00474-2
3. European Centre for Disease Prevention and Control (ECDC), European Medicines Agency (EMEA). ECDC/EMEA joint technical report. The bacterial challenge: time to react. Stockholm: ECDC, 2009. Available: http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf. Accessed: 30 March 2015.
4. US Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available: http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed: 31 March 2015.
5. Review on Antimicrobial Resistance Antimicrobial resistance: Tackling a crisis for the health and wealth of nations. 2014. Available: http://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20 a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf. Accessed: 11 December 2014.
6. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14:742-50. Medline: 25022435 doi:10.1016/S1473-3099(14)70780-7
7. World Health Organisation. WHO model prescribing information: Drugs used in bacterial infections. 2001. Available: http://apps.who.int/medicinedocs/pdf/s5406e/s5406e.pdf. Accessed: 20 July 2015.
8. Howard P, Pulcini C, Hara GL, West RM, Gould IM, Harbarth S, et al. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother. 2015;70:1245-55. Medline: 25527272
9. World Health Organisation. Antimicrobial resistance: Global report on surveillance 2014. Available: http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1. Accessed: 18 September 2014.
10. World Health Organisation. International Classification of Diseases, ICD-10 Version: 2015. Available: http://apps.who.int/classifications/icd10/browse/2015/en#/A40.0. Accessed: 8 April 2015.
11. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease study 2013. Lancet Infect Dis. 2014;385:117-71. Medline: 25530442
12. Eisinger F, Blay J-Y, Morère J-F, Rixe O, Calazel-Benque A, Cals L, et al. Cancer screening in France: subject's and physician's attitudes. Cancer Causes Control. 2008;19:431-4. Medline:18085414 doi:10.1007/s10552-007-9102-9
13. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893-902. Medline:19748398 doi:10.1016/S0140-6736(09)61204-6